Table 4. Validation of proteomic results by analysing the gene expression of the skin mRNA corresponding to the respective proteins.
Trial#1 | Trial#1 | Trial#2 | ||
---|---|---|---|---|
Primer | 2DGE fold change | P value | qPCR fold change | |
CALR | +1.2 | 0.40 | n.s | n.s. |
CALRL | +1.3 | 0.08 | +1.26† | +1.72* |
GAPDH | -1.4 | 0.03 | n.s. | n.s. |
HPXL | +1.8 | 0.05 | n.e. | n.e. |
KRT13 | -1.8 | 0.02 | n.s. | n.s. |
PPID | -1.5 | 0.02 | n.s. | n.s. |
RPLP0 | +1.3 | 0.02 | n.s. | +1.39* |
† p<0.075
* p<0.05
n.s. = not significant; n.e. = not expressed.